AUG 13, 2026 · PHASE 3 TRIAL
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
ClinicalTrials.gov
This is a Phase 3 trial registration with no posted results; the study is actively recruiting and outcome data are not yet available for analysis.
Reported
Planned enrollment400
PhasePhase 3
Primary outcome measureDisease-free survival (DFS) by investigator…